NeoGenomics
NEO
$17.41
Share price
-1.14%
Change (1 day)
43.29%
Change (1 year)
Revenue for NeoGenomics (NEO)
Revenue in 2022 (TTM): $0.50 B
According to NeoGenomics 's latest financial reports the company's current revenue (TTM) is $0.50 B. In 2021 the company made a revenue of $0.48 B an increase over the years 2020 revenue that were of $0.44 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NeoGenomics from 2003 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.50 B | 5.24% |
| 2021 | $0.48 B | 8.97% |
| 2020 | $0.44 B | 8.71% |
| 2019 | $0.40 B | 47.73% |
| 2018 | $0.27 B | 7.01% |
| 2017 | $0.25 B | 5.95% |
| 2016 | $0.24 B | 144.57% |
| 2015 | $99.8 M | 14.62% |
| 2014 | $87.06 M | 30.99% |
| 2013 | $66.46 M | 11.02% |
| 2012 | $59.86 M | 37.68% |
| 2011 | $43.48 M | 26.51% |
| 2010 | $34.37 M | 16.63% |
| 2009 | $29.46 M | 47.23% |
| 2008 | $20.01 M | 73.97% |
| 2007 | $11.5 M | 77.65% |
| 2006 | $6.47 M | 243.5% |
| 2005 | $1.88 M | 237.83% |
| 2004 | $0.55 M | 50.84% |
| 2003 | $0.36 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $9.88 B | 1,838.88% | 🇺🇸 USA |
 LabCorp LH | $14.87 B | 2,818.58% | 🇺🇸 USA |
 RadNet RDNT | $1.43 B | 180.55% | 🇺🇸 USA |
 Psychemedics PMD | $25.97 M | -94.90% | 🇺🇸 USA |
 Enzo Biochem ENZ | $81.12 M | -84.09% | 🇺🇸 USA |